Athenex Provides Update Regarding Oral Paclitaxel Plus Encequidar
06 Jul 2021 //
GLOBENEWSWIRE
Athenex Presents Updated Phase 3 Data on Survival & Tolerability Oral Paclitaxel
09 Dec 2020 //
PRESS RELEASE
Athenex Announces FDA Acceptance for Oral Paclitaxel and Encequidar
01 Sep 2020 //
GLOBENEWSWIRE
Athenex Up 13% As FDA Grants Priority Review For NDA Of Breast Cancer Drug
01 Sep 2020 //
NASDAQ